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A B S T R A C T
The pathophysiology of inflammatory bowel disease (IBD) reflects a balance between mucosal injury and re-
parative mechanisms. Some regenerating gene (Reg) family members have been reported to be expressed in
Crohn's disease (CD) and ulcerative colitis (UC) and to be involved as proliferative mucosal factors in IBD.
However, expression of all REG family genes in IBD is still unclear. Here, we analyzed expression of all REG
family genes (REG Iα, REG Iβ, REG III, HIP/PAP, and REG IV) in biopsy specimens of UC and CD by real-time RT-
PCR. REG Iα, REG Iβ, and REG IV genes were overexpressed in CD samples. REG IV gene was also overexpressed
in UC samples. We further analyzed the expression mechanisms of REG Iα, REG Iβ, and REG IV genes in human
colon cells. The expression of REG Iα was significantly induced by IL-6 or IL-22, and REG Iβ was induced by IL-
22. Deletion analyses revealed that three regions (− 220 to − 211, − 179 to − 156, and − 146 to − 130) in
REG Iα and the region (− 274 to− 260) in REG Iβ promoter were responsible for the activation by IL-22/IL-6.
The promoters contain consensus transcription factor binding sequences for MZF1, RTEF1/TEAD4, and STAT3 in
REG Iα, and HLTF/FOXN2F in REG Iβ, respectively. The introduction of siRNAs for MZF1, RTEF1/TEAD4,
STAT3, and HLTF/FOXN2F abolished the transcription of REG Iα and REG Iβ. The gene activation mechanisms of
REG Iα/REG Iβ may play a role in colon mucosal regeneration in IBD.
1. Introduction
Crohn's disease (CD) and ulcerative colitis (UC), the two primary
forms of idiopathic human inflammatory bowel disease (IBD), are both
characterized by chronic, destructive intestinal inflammation of un-
known cause(s). Despite advances over the past decade in our under-
standing of cellular and molecular mechanisms underlying chronic in-
flammation, the precise etiopathogenic factors in IBD remain
undefined. Current theories suggest that interplay between environ-
mental, genetic, microbial, and immunologic factors results in the
chronic gut inflammation that characterizes CD or UC.
Regenerating gene (REG) family proteins are structurally similar
proteins belonging to the calcium-dependent (C-type) lectin super-
family. In humans, five REG family genes (i.e., REG Iα, REG Iβ, REG-
related sequence (pseudogene), HIP/PAP (INGAP), and REG III) are
tandemly ordered in the 95 kbp region of chromosome 2p12, whereas
REG IV is located on chromosome 1q12-q21 [1,2]. The first Reg gene
was discovered in rat regenerating pancreatic islets and involved in β-
cell regeneration [3], and Reg proteins have since been found in other
physiological and pathophysiological processes [1,2]. Their basic bio-
logical effects seem to be induction of cellular proliferation [4–7]. Reg
family proteins have been suggested to be involved in cellular
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proliferation in gastrointestinal cells [1,2,8]. Elsewhere in the gastro-
intestinal system, these proteins are found during tissue injury [1,2].
They are also overexpressed in gastric and colorectal cancers [9–12]
and in colorectal cancer cell lines [13].
Concerning IBD, overexpression of REG Iα and REG Iβ mRNA in
resected colonic tissue from CD and UC was first reported by Lawrance
et al. [14]. We also showed the overexpression of HIP/PAP and REG III
in IBD [15]. Subsequently, overexpression of REG Iα, REG Iβ, and REG
III in IBD colon was reported [16,17]. Overexpression of REG Iα mRNA
and protein in UC, particularly in dysplasia or cancer, and a possible
role for REG Iα as a marker for UC-associated neoplasia were also re-
ported [18]. Recently, Granlund et al. analyzed four of REG family
genes in five functional human REG family members, and found that the
analyzed four genes (REG Iα, REG Iβ, HIP/PAP, and REG IV) were
overexpressed in IBD samples [19].
Although we and others have previously suggested that REG family
proteins have a trophic effect on mammalian epithelial cells and are
involved in IBD, expression of all functional members of REG family
genes (REG Iα, REG Iβ, REG III, HIP/PAP, and REG IV) in IBD is still
unclear. In the present study, we examined all five REG family genes in
IBD and found overexpression of REG Iα, REG Iβ, and REG IV mRNAs in
CD and that of REG IV mRNA in UC. Reporter gene assays and siRNA-
mediated knockdown experiments indicated that the overexpression of
REG Iα, REG Iβ, and REG IV mRNA was mediated through several
transcription factors, including myeloid zinc finger 1 (MZF1), related
transcriptional enhancer factor-1 (RTEF1)/TEA Domain transcription
Factor 4 (TEAD4), and signal transducer and activator of transcription 3
(STAT3) in REG Iα, helicase-like transcription factor (HLTF)/forkhead
box protein N2 (FOXN2) in REG Iβ, and GATA DNA-binding protein 6
(GATA6) in REG IV gene expression.
2. Materials and methods
2.1. Tissue specimens and histological examination
Patients admitted to the Gastrointestinal Endoscopy Unit,
Department of Gastroenterology, Saiseikai Nara Hospital (Nara, Japan)
or Nara Medical University Hospital (Kashihara, Japan) for colonoscopy
were included after informed consent. Colon biopsy samples were ob-
tained from the rectum by endoscopy from 49 patients with CD (36 men
and 13 women; mean age 33.21± 2.32 years, range 0.4–79) and 39
patients with UC (21 men and 18 women; mean age 43.07± 2.58,
range 16–75). Normal control specimens were obtained from resected
colon for cancer (44 patients, 26 men and 18 women; mean age
66.78± 1.65, range 43–91) and were used as normal control. The
tissue specimens were fixed in 10% formalin solution, embedded in
paraffin, and subjected to histopathological analyses.
This work was done with approval of the Review Board(s) of
Saiseikai Nara Hospital and Nara Medical University Hospital. The di-
agnosis of UC was based on established endoscopic and histologic cri-
teria [20].
2.2. Real-time RT-PCR
Total RNA was isolated from formalin-fixed, paraffin-embedded
tissue specimens and from human colonic epithelial cells (HT-29 and
LS-174T cells) using RNeasy FFPE Kit (Qiagen, Hilden, Germany) and
RNeasy Protect Cell Mini Kit (Qiagen), respectively. The isolated RNA
was reverse transcribed to the cDNA using High Capacity cDNA
Synthesis Kit (Applied Biosystems, Foster City, CA) for the template of
real-time PCR as described [21–27]. The cDNA was subjected to PCR
with the following primers: β-actin (NM_001101) sense primer, 5’-GC-
GAGAAGATGACCCAGA-3’ and antisense primer, 5’-CAGAGGCGTAC-
AGGGATA-3’; REG Iα (NM_002909) sense primer, 5’-AGGAGAGTGGC-
ACTGATGACTT-3’ and antisense primer 5’-TAGGAGA
CCAGGGACCCACTG-3’; REG Iβ (NM_006507) sense primer, 5’-
GCTGATCTCCTCCCTGATGTTC-3’ and antisense primer, 5’-TGTCAGT-
GATCTTGGTTTGAA-3’; REG III (AB161037) sense primer, 5’-GAATA-
TTCTCCCCAAACTG-3’ and antisense primer, 5’-GAGAAAAG
CCTGAAATGAAG-3’; HIP/PAP (NM_138937) sense primer, 5’-AGAGA-
ATATTCGCTTAATTCC-3’ and antisense primer, 5’-AATGAAGAGACT-
GAAATGACA-3’; and REG IV (AY007243) sense primer, 5’-ATCCTGG-
TCTGGCAAGTC-3’ and antisense primer, 5’-CGTTGCTGCTCCAAGTTA-
3’. All the PCR primers were synthesized by Nihon Gene Research La-
boratories (Sendai, Japan). Real-time PCR was performed using KAPA
SYBR® FAST qPCR Master Mix (Kapa Biosystems, Boston, MA) and
Thermal Cycler Dice Real Time System (Takara Bio Inc, Kusatsu, Japan)
as described [21–27]. PCR was performed with an initial step of 3 min
at 95 °C followed by 40 cycles of 3 s at 95 °C and 20 s at 60 °C for β-
actin, REG III, and HIP/PAP; 40 cycles of 3 s at 95 °C and 20 s at 64 °C
for REG Iα, REG Iβ, and REG IV. Target cDNAs were cloned into
pBluescript SK(-) plasmid (Stratagene, La Jolla, CA), and sequential 10-
fold dilutions from 102 to 107 copies/µL were prepared. The serial di-
lutions were run to verify the specificity and to test the sensitivity of the
SYBR Green-based real-time RT-PCR. Target mRNA value was nor-
malized to that of β-actin mRNA, which was used to account for dif-
ferences in the efficiency of reverse transcription between samples.
2.3. Cell culture and treatment
LS-174T and HT-29 human colonic epithelial cells were grown in
RPMI 1640 medium (Nakarai Tesque, Inc., Kyoto, Japan) supplemented
with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL
streptomycin (Wako) [23]. Human interleukin (IL)− 6 and tumor ne-
crosis factor (TNF)α were purchased from Roche Diagnostics (In-
dianapolis, IN), and human IL-8, IL-17A, IL-22, hepatocyte growth
factor (HGF), basic fibroblast growth factor (bFGF), and epidermal
growth factor (EGF) were fromWako. Cells were treated with 20 ng/mL
IL-6, 10 nM IL-8, 1 µg/mL IL-17A, 20 ng/mL IL-22, 20 ng/mL TNFα,
50 ng/mL HGF, 10 nM bFGF, and 10 nM EGF for 24 h.
2.4. Promoter assay
The reporter constructs were prepared by inserting fragments of
human REG Iα gene promoter (− 1190 to + 26,− 402 to + 26,− 370
to + 26, − 345 to + 26, − 301 to + 26, − 258 to + 26, − 247 to +
26,− 234 to + 26,− 226 to + 26,− 220 to + 26,− 211 to + 26,−
204 to + 26,− 179 to + 26,− 156 to + 26,− 146 to + 26,− 130 to
+ 26) [25,26], human REG Iβ gene promoter (− 978 to + 30. − 806
to + 30, − 622 to + 30, − 562 to + 30, − 525 to + 30, − 478 to +
30, 441 to + 30, − 381 to + 30, − 326 to + 30, − 298 to + 30, −
274 to + 30, − 260 to + 30) [25] and human REG IV (− 1053 to +
22) upstream of a firefly luciferase reporter gene in pGL3-Basic vector
(Promega, Madison, WI). The cells were grown in 24-well plates to
70–80% confluency and were transfected with reporter plasmids by
lipofection. Briefly, 0.5 µg of each reporter plasmid and, as an internal
control, 0.05 µg of pCMV-SPORT-β-galactosidase (Invitrogen, Carlsbad,
CA) per well were mixed with Lipofectamine®3000 (Invitrogen) in a 24-
well plate. After 24 h, the medium of each well was replaced with fresh
medium containing stimulants and incubated further for 24 h. Cells
were washed twice with PBS and extracts were prepared in extraction
buffer (0.1 M potassium phosphate, pH 7.8/0.2% Triton X-100) as de-
scribed [25–27]. Luciferase activity was measured using a PicaGene®
Luciferase assay system (Toyo-ink, Tokyo, Japan) and was normalized
by the β-galactosidase activity as described [25–27].
2.5. RNA interference (RNAi)
Small interfering RNA (siRNA)s directed against human MZF1,
RTEF1/TEAD4, HLTF/FOXN2, STAT3, suppressors of the cytokine sig-
naling 3 (SOCS3), caudal-type homeobox transcription factor 2 (CDX2),
and GATA DNA-binding protein 6 (GATA6) were synthesized by Nihon
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Gene Research Laboratories. The sense sequences of siRNA for human
MZF1, RTEF1/TEAD4, HLTF/FOXN2, STAT3, SOCS3, CDX2, and
GATA6 were as follows: 5’-GAGGUCCUAUCAGAGAAGAtt-3’ for MZF1,
5’-GGGCAGACCUCAACACCAAtt-3’ for RTEF1/TESD4, 5’-GGAAUUU
UAGCUGAUGAUAtt-3’ for HLTF/FOXN2, 5’-GCACCUUCCUG
CUAAGAUUtt-3’ for STAT3, 5’-CCAAGAACCUGCGCAUCCAtt-3’ for
SOCS3, 5’-AAGCCUCAGUGUCUGGCUCUGtt-3’ for CDX2, and 5’-
GACAGAACGUGAUUCUCGUtt-3’ for GATA6. siRNA-scramble
(Ambion®, Life Technologies) [25–27] was also used as a control.
Transfection of siRNA to LS-174T cells was carried out using Lipo-
fectamine® RNAiMAX (Thermo Fischer Scientific, Waltham, MA). Cells
were transfected with 5 pmol of siRNA in a 24-well culture dish (4 ×
105 cells/mL) as described [25–27].
2.6. Statistical analysis
All values for real-time RT-PCR were expressed as mean± SE. The
data were analyzed by unpaired two-tailed t-test using GraphPad
Prism6 (GraphPad Software, La Jolla, CA). P value of< 0.05 was
considered to be statistically significant.
3. Results
3.1. Expression of the REG family genes in IBD colon mucosa
REG family gene activation in the colon was evaluated in 88 patients
with IBD (39 UC and 49 CD patients) and 44 controls (normal mucosa
of surgical resected colon cancer specimens) from Saiseikai Nara
Hospital and Nara Medical University Hospital. Patients with IBD were
younger than control patients (mean± SE ages of UC, CD, and control
were 43.07±2.58, 33.21± 2.32, and 66.78± 1.65 years old, respec-
tively).
We extracted total RNA from the colon specimens and measured all
REG family (REG Iα, REG Iβ, REG III, HIP/PAP, and REG IV) mRNA
expression by real-time RT-PCR and found that REG Iα, REG Iβ, and REG
IV genes were overexpressed in CD colon samples (Fig. 1A, B, and E).
The REG IV gene was also overexpressed in UC colon samples (Fig. 1E).
In contrast, the expression of type III REG genes (REG III and HIP/PAP)
was not changed in IBD colon samples (Fig. 1C and D).
3.2. Transcription of REG Iα is activated by IL-22 and IL-6 via MZF1,
RTEF1/TEAD4, and STAT3
IL-6 and IL-8 are reported to induce REG family mRNA in vitro
[8,28,29] and in vivo [22,30], and IL-22 [31], TNFα [32], IL-17A [33],
bFGF [34], HGF [35], and EGF [34] are also reported to induce REG
family mRNA(s). To verify whether REG Iα gene expression is up-
regulated by cytokine(s)/growth factor(s) in colon epithelial cells, we
introduced luciferase reporter plasmid(s) containing REG Iα promoter
(− 1190 to + 26) into colon epithelial cells (LS-174T and HT-29),
stimulated by IL-6, IL-8, IL-17A, IL-22, TNFα, bFGF, HGF, or EGF, and
measured transcriptional activities. As shown in Fig. 2A and B, REG Iα
transcription was significantly increased by the addition of IL-6 and IL-
22, and the IL-22-induced promoter activity of REG Iα showed greater
increase than the IL-6-induced promoter activity in both LS-174T and
HT-29 human colon cells.
To map out the cis-element of REG Iα promoters that are responsible
for REG Iα transcription in response to IL-22/IL-6 in colon epithelial
cells, several lengths of REG Iα promoters were fused to the luciferase
gene. After transfection of the reporter plasmid, cells were stimulated
by IL-22 or IL-6 and transcriptional activity was measured. As shown in
Fig. 2C, the deletion down to position − 220 in REG Iα promoter did
not alter significantly the expression of the IL-22-induced reporter ac-
tivation, but additional deletions to nucleotide − 211 (− 220 to −
211), − 179 to − 156, and − 146 to − 130 caused remarkable de-
creases of promoter activities. These results indicate that the regions of
− 220 to − 211, − 179 to − 156, and − 146 to − 130 contain
essential cis-elements for the IL-22 induced REG Iα promoter activities.
A computer-aided search for sequences similar to known cis-acting
element(s) revealed that each region has a possible binding site for
MZF1, RTEF1/TEAD4, and STAT3, respectively.
We also tested nested deletion constructs of REG Iα reporter plas-
mids in the IL-6-induced REG Iα promoter activation. The deletion
analyses showed that the essential regions for the IL-22-induced REG Iα
promoter activation were also essential for the IL-6-induced REG Iα
promoter (Fig. 2D), indicating that IL-6-induced REG Iα activation oc-
curs in the same mechanism as IL-22-induced REG Iα activation.
To investigate the significance of MZF1, RTEF1/TEAD4, and STAT3
in IL-22-induced REG Iα expression in colon epithelial cells, we used
RNA interference of MZF1, RTEF1/TEAD4, and STAT3 to identify
whether these factors are essential for the IL-22-induced transcription
of the REG Iα gene. As shown in Fig. 2E, the introduction of either
MZF1, RTEF1/TEAD4, or STAT3 siRNA into the LS-174T cells sig-
nificantly reduced the IL-22-induced expression of REG Iα mRNA as
compared to no siRNA or scrambled siRNA introduction.
3.3. Transcription of REG Iβ is activated by IL-22 via HLTF/FOXN2
IL-22 showed significant increase in REG Iβ promoter activation, but
the other cytokines/growth factors did not (Fig. 3A). Progressive de-
letions of the REG Iβ promoter gene were performed, the deleted con-
structs were transfected into LS-174T cells, and the IL-22-induced
promoter activities were measured. The deletion analyses of REG Iβ
promoter revealed that the − 274 to − 260 region was important for
the IL-22-induced REG Iβ promoter activation (Fig. 3B), and that the
region contains a possible HLTF/FOXN2 binding site.
To investigate the significance of HLTF/FOXN2 for REG Iβ expres-
sion in colon epithelial cells, we used RNA interference of HLTF/FOXN2
to verify whether HLTF/FOXN2 is essential for the IL-22-induced
transcription of REG Iβ gene. As shown in Fig. 3C, the introduction of
HLTF/FOXN2 siRNA significantly reduced the IL-22-induced REG Iβ
mRNA as compared to no siRNA or scrambled siRNA introduction.
3.4. GATA6 is required for REG IV expression
In REG IV promoter, no enhanced promoter activity was detected in
all the cytokine/growth factor additions (IL-6, IL-8, IL-17A, IL-22,
TNFα, HGF, bFGF, and EGF) in LS-174T cells. On the other hand, TNFα
significantly decreased the REG IV promoter activity in LS-174T cells
(Fig. 4A).
Concerning the TNFα-induced suppression of REG IV transcription,
we tested siRNAs for CDX2, SOCS3, and GATA6 as CDX2 [36] and G-
ATA6 [37] were reported to be involved in REG IV gene expression and
TNFα was reported to control SOCS3 expression [38], and found that
GATA6 siRNA abolished the TNFα-induced suppression of REG IV ex-
pression as compared to no siRNA or scrambled siRNA (Fig. 4B). This
indicates that GATA6 but not CDX2 nor SOCS3 is an essential tran-
scription factor for REG IV expression in colon epithelial cells and is
responsible for the TNFα-induced suppression of REG IV expression.
4. Discussion
The pathophysiology of IBD such as UC and CD reflects a balance
between mucosal injury related to an ongoing inflammatory process
and mucosal reparative mechanisms. As proliferative mucosal factors
may offer new therapeutic paradigms, Dieckgraefe et al. searched such
candidate genes and found that REG family genes (REG Iα, REG Iβ, and
HIP/PAP) were highly expressed in IBD colonic mucosa [17]. Ogawa
et al. found that Reg IIIβ and Reg IIIγ were overexpressed in sodium
dextran sulfate-induced mouse colitis as well as in a murine bacterial
reconstitution model, and that HIP/PAP was overexpressed in human
IBD colonic mucosa [15]. Numerous papers on expression analyses in
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one or more members of REG family genes in IBD mucosa followed
these findings [16,18,19,31,39]. Despite these reports, expression of all
members of REG family genes in IBD lesions has not been clarified. In
the present study, we analyzed expression of all REG family mRNAs
(REG Iα, REG Iβ, REG III, HIP/PAP, and REG IV) in CD and UC samples
and found that REG family genes (REG Iα, REG Iβ, and REG IV) were
overexpressed in CD colons and that the REG IV gene was also over-
expressed in UC samples. In the present study, we used normal parts of
resected colon cancer as normal ‘control’ and therefore the patients (CD
and UC) were much younger than ‘control’. As Perfetti et al. showed
that mouse pancreatic Reg I (mouse counterpart of REG Iα/REG Iβ)
mRNA levels declined with age [40], we additionally analyzed 21 much
younger control samples (mean age 15.6 years old) and found that
mRNA levels of REG Iα, REG Iβ, and REG IV in the younger controls
were not significantly different from those of ‘control’ in Fig. 1 (data not
shown). In addition, we also analyzed REG family gene expression in
another IBD, Celiac disease [41]. In subjects from Barcelona (12 Celiac
disease patients before gluten-free diet and 10 age-related controls), we
found that any of the REG family genes were not overexpressed in
Celiac disease samples (Supplemental Fig. 1), suggesting that the REG
family gene expression and its role(s) in disease progression are dif-
ferent among CD, UC, and Celiac disease, and the significance of the
REG family gene expression as biomarkers is different. The autoimmune
condition of Celiac disease and the role of some REG proteins as au-
toantigens [22,42, 43] may contribute to explain these differences.
Originally, Reg was isolated as a gene specifically expressed in re-
generating rat islets induced by 90% pancreatectomy with poly(ADP-
ribose) polymerase inhibitor (such as nicotinamide and 3-aminobeza-
mide) administrations [2,3]. The Reg and Reg-related genes were iso-
lated and were revealed to constitute a multigene family, the Reg gene
family [1,2]. Based on the primary structures of the Reg proteins, the
members of the family are grouped into four subclasses; types I, II, III,
and IV [1]. In humans, five REG family genes, i.e., REG Iα [3,9], REG Iβ
[44], REG-related sequence (pseudogene) (RS) [9], HIP/PAP [45, 46],
and REG III [47] are tandemly ordered in the 95 kbp region of chro-
mosome 2p12 [48], whereas REG IV locates on chromosome 1 [49]. In
mouse genome, all Reg family genes except for Reg IV (i.e., Reg I, Reg II,
Reg IIIα, Reg IIIβ, Reg IIIγ, and Reg IIIδ) were mapped to a contiguous 75
kbp region of chromosome 6 C [50], whereas Reg IV was mapped on
chromosome 3. Type I (and type II) Reg proteins are expressed in re-
generating islets [1] and are involved in β-cell regeneration [4,5,42,
51]. Reg family proteins have been suggested to be involved in cellular
proliferation in gastrointestinal cells [52], hepatic cells [53], cardio-
vascular cells [30] and neuronal cells. Importantly, mouse Reg III was
shown to be a Schwann cell mitogen that accompanies the regeneration
of motor neurons [54], and Reg protein functions as a neurotrophic
factor for motor neurons [54, 55]. Reg protein was also shown to
mediate gastrointestinal epithelial cell proliferation in rats [56, 57].
Yonemura et al. showed that the expression of the REG Iα gene is closely
related to the infiltrating property of gastric carcinoma, and may be a
prognostic indicator of differentiated adenocarcinoma of the stomach
[11]. In fact, following publication of this paper, correlations were re-
ported between REG family gene expression and cancer prognosis
[11,12,24,58]. These observations suggest that the Reg gene family is
involved in cell proliferation in a variety of cell types, including gas-
trointestinal cells.
In the present study, overexpression of REG Iα, REG Iβ, and REG IV
in CD and of REG IV in UC colon mucosa was detected. It was reported
previously that the REG family genes were expressed not only in various
human inflammatory diseases such as gastritis [59], pancreatitis [60],
salivary glanditis [22,26], and colitis [15], but also in various experi-
mental models of inflammation in animal tissues [30,61]. REG Iα and
REG Iβ were recently reported to be upregulated in human intestine
during Entamoeba histolytica-infected acute colitis, and intestinal epi-
thelia cells from Reg I (mouse counterpart of REG Iα/REG Iβ) knockout
mice were found to be more susceptible to spontaneous, and parasite-
induced, apoptosis [62], suggesting that REG Iα and REG Iβ could
function to protect the intestinal epithelium from parasite-induced
Fig. 1. Expression of the REG family mRNAs in CD and UC colons. Expression of REG Iα (A), REG Iβ (B), REG III (C), HIP/PAP (D), and REG IV (E) was measured by real-time RT-PCR. The
mRNA levels of REG Iα, REG Iβ, and REG IV in the CD colon were significantly higher than those of the control (P = 0.0002, 0.0011, and 0.0036, respectively). The mRNA level of REG IV
in the UC colon was higher than that of the control (P = 0.0083). The mRNA levels of REG III and HIP/PAP were not different among control, CD, and UC. Data are expressed as
mean± SE for each group (n = 44 (Control), 49 (CD), and 39 (UC)). The statistical analyses were performed using Student's t-test.
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apoptosis. Thus, it is most likely that inflammation, regardless of
whether it is autoimmune associated, is a key event that triggers REG
family gene expression in many tissues. Therefore, whether REG family
overexpression is associated directly with the immune disorder in pa-
tients with IBD is an interesting question. We performed real-time RT-
PCR analyses of all REG family genes in IBD samples and found
overexpression of REG Iα, REG Iβ, and REG IV in CD and of REG IV in UC
colon mucosa (Fig. 1). These results support the idea that REG family
mRNA overexpression is associated with inflammation triggered by
autoimmune disorders such as IBD.
It was reported that Reg gene expression was regulated by several
factors, such as nicotinamide [28,30], glucocorticoids [28], nutrient
Fig. 2. Transcriptional activation of REG Iα by IL-22 and IL-6 via MZF1, RTEF1, and STAT3. Promoter activities of REG Iα in LS-174T (A) and HT-29 cells (B) stimulated with IL-6, IL-8, IL-
17A, IL-22, TNFα, HGF, bFGF, or EGF were measured. The statistical analyses were performed using Student's t-test. Deletion analysis of REG Iα stimulated by IL-22 (C) and IL-6 (D).
Human LS-174T cells were transfected with constructs containing various deletion mutants of REG Iα promoter. Constructs listed on ordinate are numbered according to their 5’ terminus
in the REG Iα promoter. The transfected cells were stimulated with IL-22 (20 ng/mL) (C) or IL-6 (20 ng/mL) (D), after which the luciferase activities were measured. The diagram
represents fold increase of luciferase activities to the untreated cells. All data are represented as the mean± SE of the samples (n = 4). The statistical analyses were performed using
Student's t-test against no addition. Effects of siRNA transfection on IL-22-induced increase of REG Iα mRNA in LS-174T cells (E). After siRNA was introduced, LS-174T human colon
epithelial cells were stimulated with IL-22 (20 ng/mL). The expression of REG Iα (E) mRNA was measured by real-time RT-PCR using β-actin as an endogenous control. Data are expressed
as mean fold (vs no addition)± SE for each group (n = 4). The statistical analyses were performed using Student's t-test.
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factors [63], IL-6 [25,26,28], IL-8 [29], IL-17A [62], IL-22 [31], TNFα
[32], HGF [35], bFGF [34], and EGF [34]. We tested the induction of
REG Iα, REG Iβ, and REG IV by IL-6, IL-8, IL-17A, IL-22, TNFα, HGF,
bFGF, and EGF and found that REG Iα was induced by IL-22/IL-6 via
transcription factor(s) MZF1, RTEF1/TEAD4, and STAT3 (Fig. 1) and
that REG Iβ was induced by IL-22 via HLTF/FOXN2 (Fig. 2). Recent
reports have identified a crucial role for IL-22 in the regulation of both
gut inflammation and epithelial barrier integrity. IL-22 gene delivery
leads to rapid amelioration of dextran sodium sulfate-induced colitis
[65], whereas IL-22 knockout mice show increased intestinal epithelial
damage, along with systemic bacterial burden and significantly in-
creased mortality [66]. Sekikawa et al. reported that IL-22 induced REG
Iα expression via STAT3 in UC [31]. IL-6 signaling is thought to be of
central importance for the maintenance of chronic intestinal
Fig. 3. Transcriptional activation of REG Iβ by IL-22 via HLTF. (A) Promoter activities of REG Iβ in LS-174T cells stimulated with IL-6, IL-8, IL-17A, IL-22, TNFα, HGF, bFGF, or EGF were
measured. The statistical analyses were performed using Student's t-test. (B) Deletion analysis of REG Iβ promoter. Human LS-174T cells were transfected with constructs containing
various deletion mutants of REG Iβ promoter. Constructs listed on ordinate are numbered according to their 5’ terminus in the REG Iβ promoter. The transfected cells were stimulated with
IL-22 (20 ng/mL), after which the luciferase activities were measured. The diagram represents fold increase of luciferase activities to the untreated cells. All data are represented as the
mean± SE of the samples (n = 4). The statistical analyses were performed using Student's t-test against no addition. (C) Effects of siRNA transfection on IL-22-induced increase of REG Iβ
mRNA in LS-174T cells. After siRNA was introduced, LS-174T human colon epithelial cells were stimulated with IL-22 (20 ng/mL). The expression of REG IβmRNA was measured by real-
time RT-PCR using β-actin as an endogenous control. Data are expressed as mean fold (vs no addition)± SE for each group (n = 4). The statistical analyses were performed using
Student's t-test.
Fig. 4. Requirement of GATA6 in REG IV expression. (A) Promoter activities of REG IV in LS-174T cells stimulated with IL-6, IL-8, IL-17A, IL-22, TNFα, HGF, bFGF, or EGF were
measured. The statistical analyses were performed using Student's t-test. (B) Effects of siRNA transfection on TNFα-induced decrease of REG IV mRNA. After siRNA was introduced, LS-
174T human colon epithelial cells were stimulated with TNFα (20 ng/mL). The expression of REG IV mRNA was measured by real-time RT-PCR using β-actin as an endogenous control.
Data are expressed as mean fold (vs no addition)± SE for each group (n = 4). The statistical analyses were performed using Student's t-test.
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inflammation in IBD such as CD and UC. IL-6 has also been implicated
in the pathogenesis of colorectal cancer. In fact, IL-6 directly promotes
tumor cell proliferation and survival through STAT3 activation. Due to
its role in both types of diseases, IL-6 has been proposed as a missing
link between inflammation and tumor development in the colon [67].
In this study, we showed the IL-22/IL-6-induced up-regulation of
REG Iα and REG Iβ in LS-174T and HT-29 human colon cells and their
molecular mechanism(s) in which several transcription factors (MZF1,
RTEF1/TEAD4, and STAT3 in REG Iα, and HLTF/FOXN2 in REG Iβ)
were involved. Recently, MZF1 was reported to be involved in color-
ectal cancer [68], and RTEF1/TEAD4 was associated with increased
growth of gastric cancer [69]. Accumulating evidence indicates that IL-
22/IL-6-STAT3 signaling is important in tumorigenesis and tumor
growth of colitis-associated colorectal cancer [70]. HLTF/FOXN2 was
reported to be associated with lower prognosis of glioblastoma patients
[71]. These associations between transcription factors and cancer
tumor growth/poor prognosis of cancer patients may be mediated via
up-regulation of REG Iα/REG Iβ.
Up-regulation of REG IV gene in IBD has been reported previously
[34,39,72]. However, the mechanism of REG IV expression in the colon
is still controversial: Involvements of CDX2 [36] and GATA6 [37] were
reported. In the present study, we found that REG IV mRNA was sig-
nificantly up-regulated in UC and CD samples and down-regulated by
the addition of TNFα in cultured colon cells. We therefore introduced
siRNAs for CDX2, GATA6, and SOCS3 into LS-174T colon cells and
evaluated the effect of the siRNAs on the TNFα-induced suppression.
The introduction of GATA6 siRNA, but not CDX2 nor SOCS3 siRNA, was
significantly attenuated the TNFα-induced REG IV suppression (Fig. 4),
indicating that GATA6 is essential for REG IV expression and TNFα-
induced REG IV suppression in colon epithelial cells.
Up-regulation of REG Iα, REG Iβ, and REG IV may have two con-
flicting sides like Dr. Jekyll and Mr. Hyde. The expression induces to
protect/recover the intestinal epithelium from immune-mediated da-
mages by proliferation of intestinal epithelial cells by REG family pro-
teins in UC and CD. On the other hand, it may sometimes result in an
increased risk of colon cancer. Therefore, long lasting IL-22/IL-6 pro-
duction and the IL-22/IL-6-induced REG family gene up-regulation
should be monitored and controlled for healthy recovery of intestinal
epithelium. After recovery of damaged epithelium, anti-IL-22/anti-IL-6
antibodies or anti-REG family proteins may be a possible new pre-
ventive therapy to reduce colon cancer risk in UC and CD patients.
In the present study, we analyzed the expression of all REG family
genes and found overexpression of REG Iα, REG Iβ, and REG IV in IBD.
We tested cytokines that were reported to regulate the expression of the
Reg family genes, regardless of whether they activate them, and found
that IL-22/IL-6 up-regulated REG Iα via MZF1, RTEF1/TEAD4, and
STAT3 and that IL-22 up-regulated REG Iβ via HLTF/FOXN2 in human
colon cells. We also found that TNFα down-regulated REG IV expression
via GATA6 in colon epithelial cells.
Acknowledgements
This work was supported in part by Grants-in-Aid for Scientific
Research from the Ministry of Education, Culture, Sports, Science and
Technology, Japan, Japan Science and Technology Agency, and CERCA
Programme/Generalitat de Catalunya, Catalan Government, and is in
partial fulfillment by C. Tsuchida of the degree of Doctor of Medical
Science at Nara Medical University. We would like to thank Drs.
Masakazu Segawa, Michiyoshi Hisanaga, Teruhiko Imai, Shoji
Teramoto in Saiseikai Nara Hospital for cooperating in collecting IBD
patient samples. We are also grateful to Drs. Hiroyo Ota, Kiyomi
Yoshimoto, Takanori Fujimura, Hiroki Tsujinaka, Akitaka Nonomura,
and Shigeki Sugiura from Nara Medical University for encouragement.
Appendix A. Transparency document
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.bbrep.2017.10.003.
Appendix A. Supporting information
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.bbrep.2017.10.003.
References
[1] H. Okamoto, S. Takasawa, Recent advances in the Okamoto model: the CD38-cyclic
ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor
system in β-cells, Diabetes 51 (2002) S462–S473.
[2] S. Takasawa, Regenerating gene (REG) product and its potential clinical usage,
Expert Opin. Ther. Targets 20 (2016) 541–550.
[3] K. Terazono, H. Yamamoto, S. Takasawa, K. Shiga, Y. Yonemura, Y. Tochino,
H. Okamoto, A novel gene activated in regenerating islets, J. Biol. Chem. 263
(1988) 2111–2114.
[4] T. Watanabe, Y. Yonemura, H. Yonekura, Y. Suzuki, H. Miyashita, K. Sugiyama,
et al., Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg
protein, Proc. Natl. Acad. Sci. USA 91 (1994) 3589–3592.
[5] S. Takasawa, T. Ikeda, T. Akiyama, K. Nata, K. Nakagawa, N.J. Shervani, et al.,
Cyclin D1 activation through ATF-2 in Reg-induced pancreatic β-cell regeneration,
FEBS Lett. 580 (2006) 585–591.
[6] T. Ose, Y. Kadowaki, H. Fukuhara, H. Kazumori, S. Ishihara, J. Udagawa, et al., Reg
I-knockout mice reveal its role in regulation of cell growth that is required in
generation and maintenance of the villous structure of small intestine, Oncogene 26
(2007) 349–359.
[7] W. Cui, K. De Jesus, H. Zhao, S. Takasawa, B. Shi, C.B. Srikant, J.-L. Liu,
Overexpression of Reg3α increases cell growth and the levels of cyclin D1 and CDK4
in insulinoma cells, Growth Factors 27 (2009) 195–202.
[8] A. Sekikawa, H. Fukui, S. Fujii, J. Takeda, A. Nanakin, H. Hisatsune, et al., REG Iα
protein may function as a trophic and/or anti-apoptotic factor in the development
of gastric cancer, Gastroenterology 128 (2005) 642–653.
[9] T. Watanabe, H. Yonekura, K. Terazono, H. Yamamoto, H. Okamoto, Complete
nucleotide sequence of human reg gene and its expression in normal and tumoral
tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are
one and the same product of the gene, J. Biol. Chem. 265 (1990) 7432–7439.
[10] H.C. Zheng, A. Sugawara, H. Okamoto, S. Takasawa, H. Takahashi, S. Masuda,
Y. Takano, Expression profiling of the REG gene family in colorectal carcinoma, J.
Histochem. Cytochem. 59 (2011) 106–115.
[11] Y. Yonemura, S. Sakurai, H. Yamamoto, Y. Endou, T. Kawamura, E. Bandou, et al.,
REG gene expression is associated with the infiltrating growth of gastric carcinoma,
Cancer 98 (2003) 1394–1400.
[12] D.K. Dhar, J. Udagawa, S. Ishihara, H. Otani, Y. Kinoshita, S. Takasawa, et al.,
Expression of Regenerating gene I in gastric adenocarcinomas: correlation with
tumor differentiation status and patient survival, Cancer 100 (2004) 1130–1136.
[13] A. Yamauchi, I. Takahashi, S. Takasawa, K. Nata, N. Noguchi, T. Ikeda, et al.,
Thiazolidinediones inhibit REG Iα gene transcription in gastrointestinal cancer cells,
Biochem. Biophys. Res. Commun. 379 (2009) 734–738.
[14] I.C. Lawrance, C. Fiocchi, S. Chakravarti, Ulcerative colitis and Crohn's disease:
distinctive gene expression profiles and novel susceptibility candidate genes, Hum.
Mol. Genet. 10 (2001) 445–456.
[15] H. Ogawa, K. Fukushima, H. Naito, Y. Funayama, M. Unno, K. Takahashi, et al.,
Increased expression of HIP/PAP and regenerating gene III in human inflammatory
bowel disease and a murine bacterial reconstitution model, Inflamm. Bowel Dis. 9
(2003) 162–170.
[16] F. Wu, T. Dassopoulos, L. Cope, A. Maitra, S.R. Brant, M.L. Harris, et al., Genome-
wide gene expression differences in Crohn's disease and ulcerative colitis from
endoscopic pinch biopsies: insights into distinctive pathogenesis, Inflamm. Bowel
Dis. 13 (2007) 807–821.
[17] B.K. Dieckgraefe, D.L. Crimmins, V. Landt, C. Houchen, S. Anant, R. Porche-Sorbet,
J.H. Ladenson, Expression of the regenerating gene family in inflammatory bowel
disease mucosa: reg Iα upregulation, processing, and antiapoptotic activity, J.
Investig. Med. 50 (2002) 421–434.
[18] H. Tanaka, H. Fukui, S. Fujii, A. Sekikawa, H. Yamagishi, K. Ichikawa, et al.,
Immunohistochemical analysis of REG Iα expression in ulcerative colitis-associated
neoplastic lesions, Digestion 83 (2011) 204–209.
[19] Av Granlund, V. Beisvag, S.H. Torp, A. Flatberg, P.M. Kleveland, A.E. Ostvik, et al.,
Activation of REG family proteins in colitis, Scand. J. Gastroenterol. 46 (2011)
1316–1323.
[20] S.G. Matts, The value of rectal biopsy in the diagnosisof ulcerative colitis, Quart, J.
Med. 30 (1961) 393–407.
[21] T. Masui, I. Ota, A. Itaya-Hironaka, M. Takeda, T. Kasai, A. Yamauchi, et al.,
Expression of REG III and prognosis in head and neck cancer, Oncol. Rep. 30 (2013)
573–578.
[22] K. Yoshimoto, T. Fujimoto, A. Itaya-Hironaka, T. Miyaoka, S. Sakuramoto-Tsuchida,
A. Yamauchi, et al., Involvement of autoimmunity to REG, a regeneration factor, in
patients with primary Sjögren's syndrome, Clin. Exp. Immunol. 174 (2013) 1–9.
[23] K. Nakagawa, S. Takasawa, K. Nata, A. Yamauchi, A. Itaya-Hironaka, H. Ota, et al.,
C. Tsuchida et al. Biochemistry and Biophysics Reports 12 (2017) 198–205
204
Prevention of Reg I-induced β-cell apoptosis by IL-6/dexamethasone through acti-
vation of HGF gene regulation, Biochim. Biophys. Acta 2013 (1833) 2988–2995.
[24] M. Kimura, H. Naito, T. Tojo, A. Itaya-Hironaka, Y. Dohi, M. Yoshimura, et al., REG
Iα gene expression is linked with the poor prognosis of lung adenocarcinoma and
squamous cell carcinoma patients via discrete mechanisms, Oncol. Rep. 30 (2013)
2625–2631.
[25] A. Yamauchi, A. Itaya-Hironaka, S. Sakuramoto-Tsuchida, M. Takeda,
K. Yoshimoto, T. Miyaoka, et al., Synergistic activations of REG Iα and REG Iβ
promoters by IL-6 and glucocorticoids through JAK/STAT pathway in human
pancreatic β cells, J. Diabetes Res. 2015 (2015) 173058.
[26] T. Fujimura, T. Fujimoto, A. Itaya-Hironaka, T. Miyaoka, K. Yoshimoto,
A. Yamauchi, et al., Interleukin-6/STAT pathway is responsible for the induction of
gene expression of REG Iα, a new auto-antigen in Sjögren's syndrome patients, in
salivary duct epithelial cells, Biochem. Biophy. Rep 2 (2015) 69–74.
[27] H. Tsujinaka, A. Itaya-Hironaka, A. Yamauchi, S. Sakuramoto-Tsuchida, H. Ota,
M. Takeda, et al., Human retinal pigment epithelial cell proliferation by the com-
bined stimulation of hydroquinone and advanced glycation end-products via up-
regulation of VEGF gene, Biochem. Biophys. Rep. 2 (2015) 123–131.
[28] T. Akiyama, S. Takasawa, K. Nata, S. Kobayashi, M. Abe, N.J. Shervani, et al.,
Activation of Reg gene, a gene for insulin-producing β-cell regeneration: poly(adp-
ribose) polymerase binds Reg promoter and regulates the transcription by autopoly
(ADP-ribosyl)ation, Proc. Natl. Acad. Sci. USA 98 (2001) 48–53.
[29] N. Yoshino, S. Ishihara, M.A.K. Rumi, C.F. Ortega-Cava, T. Yuki, H. Kazumori, et al.,
Interleukin-8 regulates expression of Reg protein in Helicobacter pylori-infected
gastric mucosa, Am. J. Gastroenterol. 100 (2005) 2157–2166.
[30] T. Kiji, Y. Dohi, S. Takasawa, H. Okamoto, A. Nonomura, S. Taniguchi, Activation of
regenerating gene Reg in rat and human hearts in response to acute stress, Am. J.
Physiol. Heart Circ. Physiol. 289 (2005) H277–H284.
[31] A. Sekikawa, H. Fukui, K. Suzuki, T. Karibe, S. Fujii, K. Ichikawa, et al., Involvement
of the IL-22/ REG Iα axis in ulcerative colitis, Lab. Investig. 90 (2010) 496–505.
[32] M. Fujishiro, K. Nozawa, M. Kawasaki, A. Yamaguchi, K. Iwabuchi, M. Yanagida,
et al., Regenerating gene (REG) 1 alpha promotes pannus progression in patients
with rheumatoid arthritis, Mod. Rheumatol. 22 (2012) 228–237.
[33] Y. Lai, D. Li, C. Li, B. Muehleisen, K.A. Radek, H.J. Park, et al., The antimicrobial
protein REG3A regulates keratinocyte proliferation and differentiation after skin
injury, Immunity 37 (2012) 74–84.
[34] A. Nanakin, H. Fukui, S. Fujii, A. Sekikawa, N. Kanda, H. Hisatsune, et al.,
Expression of the REG IV gene in ulcerative colitis, Lab. Investig. 87 (2007)
304–314.
[35] T. Otonkoski, M.I. Mally, A. Hayek, Opposite effects of β-cell differentiation and
growth on Reg expression in human fetal pancreatic cells, Diabetes 43 (1994)
1164–1166.
[36] Y. Naito, N. Oue, T. Hinoi, N. Sakamoto, K. Sentani, H. Ohdan, et al., Reg IV is a
direct target of intestinal transcriptional factor CDX2 in gastric cancer, PLoS One 7
(2012) e47545.
[37] Y. Kawasaki, K. Matsumura, M. Miyamoto, S. Tsuji, M. Okuno, S. Suda, et al., REG4
is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis,
Sci. Rep. 5 (2015) 14291.
[38] J.G. Bode, A. Nimmesgern, J. Schmitz, F. Schaper, M. Schmitt, W. Frisch, et al., LPS
and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in
macrophages, FEBS Lett. 463 (1999) 365–370.
[39] M. Kämäräinen, K. Heiskala, S. Knuutila, M. Heiskala, O. Winqvist, L.C. Andersson,
RELP, a novel human REG-like protein with up-regulated expression in in-
flammatory and metaplastic gastrointestinal mucosa, Am. J. Pathol. 163 (2003)
11–20.
[40] R. Perfetti, J.M. Egan, M.E. Zenilman, A.R. Shuldiner, Differential expression of reg-
I and reg-II genes during aging in the normal mouse, J. Gerontol. Biol. Sci. 51A
(1996) B308–B315.
[41] M. Vives-Pi, S. Takasawa, I. Pujol-Autonell, R. Planas, E. Cabré, I. Ojanguren, et al.,
Biomarkers for diagnosis and monitoring of celiac disease, J. Clin. Gastroenterol. 47
(2013) 308–313.
[42] N.J. Shervani, S. Takasawa, Y. Uchigata, T. Akiyama, K. Nakagawa, N. Noguchi,
et al., Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients,
Eur. J. Clin. Investig. 34 (2004) 752–758.
[43] W. Gurr, M. Shaw, Y. Li, R. Sherwin, RegII is a β-cell protein and autoantigen in
diabetes of NOD mice, Diabetes 56 (2007) 34–40.
[44] S. Moriizumi, T. Watanabe, M. Unno, K. Nakagawara, Y. Suzuki, H. Miyashita,
et al., Isolation, structural determination and expression of a novel reg gene, human
reg Iβ, Biochim. Biophys. Acta 1217 (1994) 199–202.
[45] C. Lasserre, L. Christa, M.T. Simon, P. Vernier, C. Bréchot, A novel gene (HIP) ac-
tivated in human primary liver cancer, Cancer Res. 52 (1992) 5089–8095.
[46] B. Orelle, V. Keim, L. Masciotra, J.C. Dagorn, J.L. Iovanna, Human pancreatitis-
associated protein. Messenger RNA cloning and expression in pancreatic diseases, J.
Clin. Investig. 90 (1992) 2284–2291.
[47] K. Nata, Y. Liu, L. Xu, T. Ikeda, T. Akiyama, N. Noguchi, et al., Molecular cloning,
expression and chromosomal localization of a novel human REG family gene, REG
III, Gene 340 (2004) 161–170.
[48] H. Miyashita, K. Nakagawara, M. Mori, Y. Narushima, N. Noguchi, S. Moriizumi,
et al., Human REG family genes are tandemly ordered in a 95-kilobase region of
chromosome 2p12, FEBS Lett. 377 (1995) 429–433.
[49] J.C. Hartupee, H. Zhang, M.F. Bonaldo, M.B. Soares, B.K. Dieckgraefe, Isolation and
characterization of a cDNA encoding a novel member of the human regenerating
protein family: Reg IV, Biochim. Biophys. Acta 1518 (2001) 287–293.
[50] M. Abe, K. Nata, T. Akiyama, N.J. Shervani, S. Kobayashi, T. Tomioka-Kumagai,
et al., Identification of a novel Reg family gene, Reg IIIδ, and mapping of all three
types of Reg family gene in a 75 kilobase mouse genomic region, Gene 246 (2000)
111–122.
[51] R. Planas, A. Alba, J. Carrillo, M.C. Puertas, R. Ampudia, X. Pastor, et al., Reg
(regenerating) gene overexpression in islets from non-obese diabetic mice with
accelerated diabetes: role of IFNβ, Diabetologia 49 (2006) 2379–2387.
[52] Y. Kadowaki, S. Ishihara, Y. Miyaoka, M. Rumi, H. Sato, H. Kazumori, et al., Reg
protein is overexpressed in gastric cancer cells, where it activates a signal trans-
duction pathway that converges on ERK1/2 to stimulate growth, FEBS Lett. 530
(2002) 59–64.
[53] K. Harada, Y. Zen, Y. Kanemori, T.C. Chen, M.F. Chen, T.S. Yeh, et al., Human REG I
gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions,
Hepatology 33 (2001) 1036–1042.
[54] F.J. Livesey, J.A. O'Brien, M. Li, A.G. Smith, L.J. Murphy, S.P. Hunt, A Schwann cell
mitogen accompanying regeneration of motor neurons, Nature 390 (1997)
614–618.
[55] K. Namikawa, M. Fukushima, K. Murakami, A. Suzuki, S. Takasawa, H. Okamoto,
H. Kiyama, Expression of Reg/PAP family members during motor nerve regenera-
tion in rat, Biochem. Biophys. Res. Commun. 332 (2005) 126–134.
[56] H. Fukui, Y. Kinoshita, T. Maekawa, A. Okada, S. Waki, S. Hassan, et al.,
Regenerating gene protein may mediate gastric mucosal proliferation induced by
hypergastrinemia in rats, Gastroenterology 115 (1998) 1483–1493.
[57] H. Kazumori, S. Ishihara, E. Hoshino, K. Kawashima, N. Moriyama, H. Suetsugu,
et al., Neutrophil chemoattractant 2β regulates expression of the Reg gene in injured
gastric mucosa in rats, Gastroenterology 119 (2000) 1610–1622.
[58] K. Hayashi, S. Motoyama, S. Koyota, Y. Koizumi, J. Wang, S. Takasawa, et al., REG I
enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells,
Cancer Sci. 99 (2008) 2491–2495.
[59] H. Fukui, F. Franceschi, R.L. Penland, T. Sakai, A.R. Sepulveda, T. Fujimori, et al.,
Effects of Helicobacter pylori infection on the link between regenerating gene ex-
pression and serum gastrin levels in Mongolian gerbils, Lab. Investig. 83 (2003)
1777–1786.
[60] Y. Satomura, N. Sawabu, H. Ohta, H. Watanabe, O. Yamakawa, Y. Motoo, et al., The
immunohistochemical evaluation of PSP/reg-protein in normal and diseased human
pancreatic tissues, Int. J. Pancreatol. 13 (1993) 59–67.
[61] M. Asahara, S. Mushiake, S. Shimada, H. Fukui, Y. Kinoshita, C. Kawakami, et al.,
Reg gene expression is increased in rat gastric enterochromaffin-like cells following
water immersion stress, Gastroenterology 111 (1996) 45–55.
[62] K.M. Peterson, X. Guo, A.G. Elkahloun, D. Mondal, P.K. Bardhan, A. Sugawara,
et al., The expression of REG 1A and REG 1B is increased during acute amebic
colitis, Parasitol. Int. 60 (2011) 296–300.
[63] L. Qiu, E.O. List, J.J. Kopchick, Differentially expressed proteins in the pancreas of
diet-induced diabetic mice, Mol. Cell. Proteomics 4 (2005) 1311–1318.
[64] C. Loncle, L. Bonjoch, E. Folch-Puy, M. Belen Lopez-Millan, S. Lac, M.I. Molejon,
et al., IL17 functions through the novel REG3β-JAK2-STAT3 inflammatory pathway
to promote the transition from chronic pancreatitis to pancreatic cancer, Cancer
Res. 75 (2015) 4852–4862.
[65] K. Sugimoto, A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A.K. Bhan, et al.,
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis, J.
Clin. Investig. 118 (2008) 534–544.
[66] Y. Zheng, P.A. Veldez, D.M. Danilenko, Y. Hu, S.M. Sa, Q. Gong, et al., Interleukin-
22 mediates early host defense against attaching and effacing bacterial pathogens,
Nat. Med. 14 (2008) 282–289.
[67] M.J. Waldner, M.F. Neurath, Master regulator of intestinal disease: il-6 in chronic
inflammation and cancer development, Semin. Immunol. 26 (2014) 75–79.
[68] G. Chen, H. Li, X. Niu, G. Li, N. Han, X. Li, et al., Identification of key genes as-
sociated with colorectal cancer based on the transcriptional network, Pathol. Oncol.
Res. 21 (2015) 719–725.
[69] B. Lim, J.L. Park, H.J. Kim, Y.K. Park, J.H. Kim, H.A. Sohn, et al., Integrative
genomics analysis reveals the multilevel dysregulation and oncogenic character-
istics of TEAD4 in gastric cancer, Carcinogenesis 35 (2014) 1020–1027.
[70] F. Mao, M. Xu, X. Zuo, J. Yu, W. Xu, M.J. Moussalli, et al., 15-Lipoxygenase-1
suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3
signaling pathway, FASEB J. 29 (2015) 2359–2370.
[71] E. Robertson, C. Perry, R. Doherty, S. Madhusudan, Transcriptomic profiling of
forkhead box transcription factors in adult glioblastoma multiforme, Cancer
Genomics Proteomics 12 (2015) 103–112.
[72] A. van Beelen Granlund, A.E. Østvik, Ø. Brenna, S.H. Torp, B.I. Gustafsson,
A.K. Sandvik, REG gene expression in inflamed and healthy colon mucosa explored
by in situ hybridisation, Cell Tissue Res. 352 (2013) 639–646.
C. Tsuchida et al. Biochemistry and Biophysics Reports 12 (2017) 198–205
205
